The American Journal of Managed Care

Barriers and Breakthroughs Ahead for Personalizing Adjuvant Therapy: Michael Hassett, MD

Michael Hassett, MD, explains the evolving landscape of HER2-positive breast cancer treatment and the role of CDK inhibition ...
The University of Alabama at Birmingham

Stenting with medication cuts stroke risk in half for high-risk patients, UAB research shows

Supplementing a stent to medical management significantly reduced the 4-year risk of stroke by about one-half, from 6 percent ...
The Cardiology Advisor

Thrombate III Approved for Hereditary Antithrombin Deficiency in Children

The FDA has expanded the approval of Thrombate III to include pediatric patients with hATd to treat and prevent thromboembolism.
Center for Biosimilars

Real-World Data Highlight Adalimumab Biosimilar Options for Hidradenitis Suppurativa

New research reveals that switching from originator to biosimilar adalimumab for hidradenitis suppurativa may lead to reduced ...